Veraxa Biotech AG
VRXA Healthcare Biotechnology
Insiders bought in the last twelve months.
Follow VRXA
Veraxa Biotech AG (VRXA) Beneish M-score
Beneish M-score, annual
Annual newest first
| Period | Beneish M-score | Change (points) |
|---|
How the score is made up
There are no annual figures to work it out from.
How the Beneish M-score works
M = −4.84 + 0.920 × DSRI + 0.528 × GMI + 0.404 × AQI + 0.892 × SGI + 0.115 × DEPI − 0.172 × SGAI + 4.679 × TATA − 0.327 × LVGI (Beneish, 1999): eight changes in the accounts from one fiscal year to the next, which the model weighs for the pattern seen in companies that later restated their earnings. Higher is worse.
| below −2.22 | Low — no pattern the model associates with manipulation |
|---|---|
| −2.22 to −1.78 | Elevated |
| above −1.78 | Flagged by the model |
−1.78 is the cut-off usually quoted from the paper, −2.22 a common conservative one. A statistical screen, not a finding of wrongdoing.
When asset quality, depreciation or SG&A cannot be worked out, that index is set to 1, as Beneish did, and the breakdown says so; with all three missing there is no score. Depreciation includes amortisation, and asset quality leaves out securities. Not worked out for banks, insurers and REITs.
Beneish M-score against peers
| Company | Beneish M-score |
|---|---|
| MDWD MediWound Ltd. compare | −3.7× |
| CHRS Coherus Oncology, Inc. compare | −3.4× |
| IPHA Innate Pharma S.A. Sponsored ADR compare | 1.1× |
| ADAG Adagene Inc. Sponsored ADR compare | 62.0× |
| CMPX Compass Therapeutics, Inc. compare | — |
| ORMP Oramed Pharmaceuticals Inc. compare | — |
| WHWK Whitehawk Therapeutics, Inc. compare | — |
| DTIL Precision BioSciences, Inc. compare | — |
| VRXA Veraxa Biotech AG | — |
What Beneish M-score is
The Beneish M-Score combines eight year-on-year changes in the accounts into a statistical screen for patterns seen in companies that overstated earnings.
−4.84 + 0.920 × DSRI + 0.528 × GMI + 0.404 × AQI + 0.892 × SGI + 0.115 × DEPI − 0.172 × SGAI + 4.679 × TATA − 0.327 × LVGI